Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3029612	s-listab	— (—)	94	126	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Maternal care for other known or suspected fetal problems

8.35

16.09

1.3

1.4

—

Other maternal disorders predominantly related to pregnancy

6.11

15.89

1.3

1.4

—

Female infertility

6.93

14.83

1.3

1.4

—

False labour

7.49

14.17

1.4

1.3

—

Gestational diabetes (for exclusion)

4.63

13.14

1.4

1.3

—

Diabetes mellitus in pregnancy

5.68

12.85

1.4

—

Female infertility, cervigal, vaginal, other or unspecified origin

6.43

12.47

1.3

1.4

—

Postpartum haemorrhage

5.81

11.66

1.4

1.3

—

Premature rupture of membranes

7.01

11.65

1.4

1.3

—

Special screening examination for infectious and parasitic diseases

7.09

10.66

1.4

1.2

—

Perineal laceration during delivery

5.41

9.97

1.3

—

Postpartum hemorraghe, all women as controls

4.30

8.79

1.4

—

Other disorders of amniotic fluid and membranes

7.17

8.74

1.5

1.3

—

Female infertility, associated with anovulation

7.52

8.41

1.3

1.4

—

Haemorrhage in early pregnancy

5.39

8.21

1.3

1.4

—

Follow-up examination after treatment for conditions other than malignant neoplasms

5.86

8.10

1.3

1.2

—

Complications of labour and delivery

4.10

7.74

1.2

1.3

—

Medical observation and evaluation for suspected diseases and conditions

5.12

7.53

1.5

1.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

5.05

7.13

1.3

—

Other obstetric conditions, not elsewhere classified

3.44

7.08

1.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.44

7.07

1.4

—

Noninflammatory disorders of female genital tract

4.14

6.91

1.3

1.4

—

Other abnormal products of conception

4.00

6.78

1.2

1.4

—

Maternal care for other conditions predominantly related to pregnancy

4.94

6.57

1.5

1.4

—

Postpartum haemorrhage due to anatomy

3.84

6.25

1.3

1.4

—

Medical treatment for female infertility

3.67

5.89

1.3

1.4

—

Spontaneous abortion

3.58

5.67

1.4

—

Abnormal findings on antenatal screening of mother

5.90

5.62

1.5

1.3

—

Pregnancy with abortive outcome

3.19

5.51

1.2

1.3

—

Persons encountering health services for examination and investigation

4.26

5.31

1.4

1.2

—

Obesity due to excess calories

3.47

5.16

1.2

1.4

—

Postpartum hemorraghe, parous women as controls

2.97

5.06

1.4

—

Maternal care for known or suspected fetal abnormality and damage

4.90

4.95

1.4

—

Certain infectious and parasitic diseases

2.83

4.72

1.3

—

General examination and investigation of persons without complaint and reported diagnosis

3.99

4.48

1.3

1.2

—

Polycystic ovarian syndrome, broad definition

3.72

4.36

1.3

1.4

—

Procreative management

9.64

4.29

1.5

1.4

—

Excessive vomiting in pregnancy

11.69

4.27

1.6

1.5

—

Infections of genitourinary tract in pregnancy

8.01

4.06

1.5

1.4

—

Obesity

2.77

4.03

1.2

1.4

—

Obesity and other hyperalimentation

2.77

4.03

1.2

1.4

—

Symptoms and signs involving the digestive system and abdomen

2.68

3.85

1.4

1.3

—

Maternal care for known or suspected malpresentation of fetus

4.10

3.84

1.3

1.4

—

Other nutritional deficiencies

2.58

3.55

1.2

1.4

—

Contraceptive management

7.03

3.53

1.3

1.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.55

3.52

1.6

1.3

—

L02BG Aromatase inhibitors

10.00

3.49

1.2

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2.54

3.45

1.6

1.3

—

Infections with a predominantly sexual mode of transmission

2.88

3.45

1.3

1.4

—

Placenta praevia

8.59

3.26

1.3

—

Persons encountering health services in circumstances related to reproduction

6.02

3.21

1.3

—

Other problems related to primary support group, including family circumstances

4.62

3.16

1.3

—

Nausea and vomiting

5.25

3.14

1.3

1.1

—

Medicines for HER+ breast cancer

6.20

3.12

1.1

1.2

—

Depression or dysthymia

2.80

3.03

1.4

1.3

—

Other sexually transmitted chlamydial diseases

5.39

2.87

1.4

1.3

—

Postpartum haemorrhage due to retained placenta

3.06

2.80

1.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

3.23

2.77

1.5

1.2

—

Genitourinary diseases

2.93

2.76

1.3

—

Twin gestation

6.01

2.70

1.5

1.4

—

Endometriosis of pelvic peritoneum

4.94

2.69

1.3

1.4

—

Abdominal and pelvic pain

2.34

2.66

1.5

1.3

—

Symptoms and signs involving the urinary system

2.90

2.65

1.2

1.3

—

Multiple gestation

5.46

2.54

1.5

1.4

—

Congenital malformations, deformations and chromosomal abnormalities

2.26

2.47

1.4

1.3

—

Endocrine, nutritional and metabolic diseases

2.11

2.37

1.2

1.4

—

Exposure to other specified factors

2.27

2.35

1.4

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.10

2.31

1.4

1.2

—

Congenital malformations of genital organs

4.59

2.26

1.2

1.3

—

Polycystic ovarian syndrome

3.90

2.25

1.3

1.4

—

Myalgia

3.89

2.25

1.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.14

2.20

1.4

1.3

—

Tonsillectomy and adenotomy

2.05

2.18

1.5

1.3

—

Inflammatory diseases of female pelvic organs

2.08

2.18

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.37

2.18

1.5

1.2

—

Pain (limb, back, neck, head abdominally)

2.35

2.05

1.4

1.2

—

Failed induction of labour

4.01

2.04

1.3

1.5

—

Ovarian dysfunction

3.34

1.96

1.3

—

Fissure and fistula of anal and rectal regions

4.55

1.94

1.0

1.4

—

Haemorrhoids and perianal venous thrombosis

4.54

1.94

1.4

1.3

—

Ectopic pregnancy

3.75

1.93

1.3

1.4

—

Labour and delivery complicated by fetal stress [distress]

2.43

1.90

1.3

—

Injuries to the hip and thigh

3.20

1.87

1.3

—

Obesity, other/unspecified

2.65

1.86

1.1

1.4

—

Soft tissue disorders

1.83

1.85

1.3

1.4

—

Chronic diseases of tonsils and adenoids

2.00

1.84

1.5

1.3

—

Examination and observation for other reasons

2.74

1.81

1.6

1.2

—

Epilepsy

3.04

1.79

1.3

—

Dysplasia of cervi uteri

2.81

1.77

1.8

1.4

—

Neurological diseases, wide definition

2.41

1.74

1.3

—

Hypothyroidism, levothyroxine purchases

2.27

1.74

1.3

1.2

—

Hypothyroidism and >3 levothyroxin purchases

2.27

1.74

1.3

1.2

—

Long labour

2.54

1.74

1.3

—

Hypothyroidism (congenital or acquired)

2.26

1.73

1.3

1.2

—

Codes for special purposes

2.22

1.73

1.4

—

Provisional assignment of new diseases of uncertain etiology

2.22

1.73

1.4

—

Antepartum haemorrhage, not elsewhere classified

3.85

1.71

1.4

1.5

—

Unspecified mental disorder

0.00

1.70

0.0

1.3

—

Inflammatory disease of uterus

2.80

1.65

1.4

1.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.53

1.60

1.4

1.2

—

Bacterial infection, other or unspecified

3.01

1.56

1.2

1.3

—

Colonic or urogenital fistula

3.33

1.52

1.0

1.3

—

Medical abortion

1.99

1.49

1.5

1.3

—

Endometriosis ASRM stages 1,2

2.50

1.45

1.3

1.4

—

5-aminosalicylic acid

2.73

1.43

1.2

1.3

—

Oedema, not elsewhere classified

3.11

1.43

1.6

1.3

—

Dental caries, including avohilmo

2.25

1.42

1.3

1.5

—

Polycystic ovarian syndrome, consortium definition

1.75

1.42

1.4

—

Dental caries 1

2.25

1.42

1.3

1.5

—

Persons with potential health hazards related to communicable diseases

1.95

1.40

1.4

1.3

—

Any gastric operation

1.76

1.40

1.4

1.3

—

GASTRO-related operations

1.76

1.40

1.4

1.3

—

Disorders of the thyroid gland

1.75

1.38

1.3

1.4

—

Cholecystectomy

2.21

1.37

1.4

1.3

—

Migraine without aura

0.00

1.34

0.0

1.3

—

Selective serotonin reuptake inhibitors

1.75

1.34

1.5

1.2

—

Other reaction to severe stress, and adjustment disorders

2.04

1.32

1.5

1.3

—

Kela-code for severe mental illness

0.00

1.32

0.0

1.3

—

Dental caries 1, only avohilmo

2.16

1.32

1.3

1.5

—

Adverse effects, not elsewhere classified

2.50

1.30

1.7

1.3

—

Anxiety disorders, excluding more controls

1.84

1.29

1.6

1.3

—

Vasomotor and allergic rhinitis

2.10

1.29

1.6

1.2

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2.78

1.28

1.2

1.3

—

Personal history of other diseases and conditions

2.77

1.28

1.6

1.2

—

Acute upper respiratory infections

1.73

1.28

1.5

1.3

—

IBD patients in KELA-register

2.40

1.24

1.2

1.3

—

Sulfasalazine

2.40

1.24

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.69

1.24

1.8

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.98

1.23

1.4

—

Intestinal infectious diseases

1.72

1.22

1.4

1.3

—

Dental caries 2

1.75

1.21

1.3

1.4

—

Excessive, frequent and irregular menstruation

2.14

1.20

1.4

—

Inflammatory bowel disease, strict (require KELA)

2.31

1.18

1.2

1.3

—

Acetic acid derivatives and related substances

2.60

1.18

1.4

1.1

—

Dental caries 2, only avohilmo

1.73

1.18

1.2

1.4

—

Contact with and exposure to communicable diseases

1.87

1.16

1.3

1.4

—

Hypothyroidism, other/unspecified

1.67

1.16

1.3

1.4

—

Migraine without aura and triptan purchases

0.00

1.16

0.0

1.3

—

Preterm labour and delivery

2.50

1.15

1.6

1.4

—

Schizophrenia or delusion

0.00

1.15

0.0

1.3

—

Schizophrenia, schizotypal and delusional disorders

0.00

1.15

0.0

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.76

1.14

1.5

1.4

—

Neurotic, stress-related and somatoform disorders

1.68

1.12

1.6

1.3

—

Covid-19 suspected case

2.33

1.12

1.6

1.3

—

Anxiety disorders

1.67

1.11

1.6

1.3

—

Psychiatric diseases

1.67

1.09

1.3

—

Any mental disorder

1.67

1.09

1.3

—

Ulcerative colitis

2.38

1.09

1.2

1.3

—

Other arthritis (FG)

2.38

1.09

1.4

1.2

—

Persons encountering health services for specific procedures and health care

0.48

1.09

1.0

1.4

—

Fall on same level

0.52

1.08

1.1

1.4

—

Acute pharyngitis

2.36

1.08

1.4

1.2

—

Injury, poisoning and certain other consequences of external causes

1.80

1.08

1.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.63

1.06

1.3

1.4

—

Dental pulpitis 2

2.00

1.05

1.2

1.5

—

Persons encountering health services in other circumstances, wide

1.64

1.04

1.3

1.2

—

Allergic rhinitis

1.98

1.04

1.6

1.2

—

Other arrhythmias

1.97

1.04

1.6

1.3

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.75

1.03

1.5

1.4

—

COPD/asthma related infections

1.61

1.03

1.3

—

COPD/asthma/ILD related infections

1.61

1.03

1.3

—

Prolonged pregnancy

2.28

1.03

1.0

1.4

—

Dental pulpitis 2, only avohilmo

1.92

1.01

1.2

1.5

—

Irregular menses

1.70

0.99

1.4

—

Autoimmune diseases

1.57

0.99

1.2

1.4

—

Autoimmune diseases related-to ILD

1.69

0.99

1.3

—

Injuries to the elbow and forearm

1.81

0.97

1.3

—

Other viral diseases

1.89

0.93

1.3

—

Other pulmonary diagnosis

1.67

0.93

1.3

—

Parasetamol

1.58

0.93

1.2

1.4

—

COPD differential diagnosis

1.67

0.93

1.3

—

Acute sinusitis

1.77

0.92

1.4

1.2

—

Used for control exclusion in common control thyroid runs

1.55

0.91

1.2

1.4

—

Bronchitis

1.55

0.91

1.6

1.3

—

Hypothyroidism, strict autoimmune

1.63

0.91

1.3

1.4

—

Open wound of head

2.11

0.90

1.5

1.2

—

Propionic acid derivatives

2.15

0.90

1.2

1.1

—

Pre-eclampsia or poor fetal growth

1.74

0.89

1.4

—

Acute upper respiratory infections of multiple and unspecified sites

1.64

0.89

1.6

1.3

—

Cardiac arrhythmias

1.77

0.88

1.5

1.4

—

Disorders of other endocrine glands

1.87

0.87

1.3

—

Pain in limb

1.63

0.87

1.4

—

Recurrent or chronic depression

1.86

0.87

1.5

1.3

—

Abnormalities of breathing

0.52

0.86

1.5

1.3

—

Maternal care for known or suspected abnormality of pelvic organs

1.97

0.84

1.2

1.3

—

Neurological diseases

1.52

0.84

1.3

1.4

—

Other soft tissue disorders, not elsewhere classified

1.54

0.84

1.4

—

Dentofacial anomalies [including malocclusion]

1.91

0.83

1.5

1.2

—

Diseases of the respiratory system

1.72

0.83

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.62

0.82

1.5

1.3

—

Diseases of the musculoskeletal system and connective tissue

1.63

0.82

1.3

—

Dental caries 3, only avohilmo

1.76

0.82

1.3

1.4

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.88

0.81

1.3

—

Dental caries 3

1.76

0.81

1.3

1.4

—

Inflammatory bowel disease

1.88

0.81

1.2

1.3

—

Meniscus derangement

0.00

0.81

0.0

1.2

—

Chronic sinusitis

1.82

0.79

1.5

1.2

—

Other and unspecified nonorganic psychotic disorders

0.00

0.77

0.0

1.3

—

Allergic asthma (mode)

1.79

0.77

1.5

1.3

—

Allergic asthma (mode), excluding more controls

1.78

0.77

1.5

1.3

—

Schizophrenia or delusion, excluding more controls

0.00

0.77

0.0

1.3

—

Other puerperal infections

0.00

0.76

0.0

1.4

—

Endometriosis

1.89

0.75

1.3

1.4

—

Anxiety (asthma-related co-morbidities)

1.58

0.74

1.8

1.3

—

Dental caries 1 and operation codes, only avohilmo

2.09

0.74

1.2

1.5

—

Cholelithiasis

1.71

0.73

1.5

1.3

—

Poor fetal growth

1.84

0.73

1.1

1.3

—

Superficial injury of wrist and hand

2.00

0.72

1.2

1.3

—

Other functional intestinal disorders

1.98

0.72

1.2

1.3

—

Gastrointestinal diseases

1.56

0.70

1.4

1.2

—

Deforming dorsopathies

1.92

0.70

1.4

1.3

—

Excluding asthma or asthma-COPD overlap

1.56

0.70

1.2

1.3

—

ILD differential diagnosis

1.56

0.70

1.2

1.3

—

Dental caries 1 and operation codes

1.66

0.69

1.3

1.5

—

Cholelithiasis, broad definition with cholecystitis

1.67

0.68

1.5

1.3

—

Coxibs

1.90

0.68

1.4

1.1

—

Systemic connective tissue disorders

1.85

0.68

1.2

—

Covid-19 confirmed case

1.85

0.68

1.2

1.3

—

Noninfective enteritis and colitis

1.66

0.68

1.1

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.63

0.66

1.4

1.3

—

Anti-inflammatory and antirheumatic products, non-steroids

1.80

0.64

1.0

1.1

—

Nerve, nerve root and plexus disorders

0.57

0.64

1.2

1.4

—

Dental caries 2 and operation codes

1.48

0.63

1.3

1.4

—

Dental pulpitis 1, only avohilmo

0.63

1.2

1.3

—

Dental pulpitis 4, only avohilmo

0.63

1.2

1.3

—

Triptan medication for migraine, min. 3 purchases

0.57

0.62

1.3

1.4

—

Heart failure, not strict

0.00

0.62

0.0

1.1

—

Pain in joint

1.60

0.61

1.6

1.2

—

All anxiety disorders

1.49

0.61

1.8

1.3

—

Pregnancy hypertension

1.55

0.61

1.5

1.4

—

Malaise and fatigue

1.67

0.61

1.2

1.3

—

Dentinal caries

0.00

0.60

0.0

1.3

—

Other benign neoplasms of skin

0.00

0.60

0.0

1.3

—

Other benign neoplasms of skin

0.00

0.60

0.0

1.3

—

Gestational [pregnancy-induced] hypertension

1.57

0.60

1.4

—

Dental caries 3 and operation codes

1.54

0.59

1.3

1.4

—

All dysplastic lesions of the cervix uteri

1.51

0.58

1.8

1.4

—

Other and unspecified effects of external causes

1.71

0.57

1.7

1.3

—

Childhood asthma (age<16)

1.70

0.57

1.2

1.3

—

Childhood asthma (age<16), excluding more controls

1.70

0.57

1.2

1.3

—

Symptoms and signs involving the circulatory and respiratory systems

1.38

0.57

1.4

1.3

—

Pollen allergy

1.70

0.57

1.2

1.3

—

Biguanides

1.58

0.56

1.3

—

Other disorders of urethra and urinary system

1.53

0.56

1.1

1.4

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.42

0.55

1.3

1.4

—

Migraine

1.48

0.55

1.3

—

Other diseases of hard tissues of teeth

1.49

0.54

1.3

—

Other and unspecified tonsillitis

1.50

0.54

1.3

1.2

—

Persons encountering health services in other circumstances

1.54

0.53

1.3

—

1.38

0.52

1.5

1.3

—

Depression

1.40

0.51

1.4

—

Fall on same level involving ice and snow

1.50

0.51

1.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.49

0.51

1.2

1.4

—

Ovarian cyst

1.56

0.49

1.1

1.4

—

Exposure to unspecified factor

1.39

0.49

1.5

1.3

—

Other (not insulin) diabetes medications

1.51

0.48

1.3

—

Childhood allergy (age < 16)

1.48

0.47

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.46

0.46

1.4

—

Other heart diseases

1.44

0.46

1.3

—

Other diseases of upper respiratory tract

1.37

0.46

1.3

—

Dental pulpitis 4

0.70

0.44

1.3

—

Diseases of pulp and periapical tissues, including avohilmo

0.70

0.44

1.3

—

Dental pulpitis 1

0.70

0.44

1.3

—

Episodal and paroxysmal disorders

1.32

0.44

1.4

1.3

—

Complications of surgical and medical care, not elsewhere classified

0.65

0.43

1.2

1.4

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.45

0.42

1.8

1.3

—

Coronary atherosclerosis

0.00

0.42

0.0

1.1

—

Ischemic heart diseases

0.00

0.42

0.0

1.1

—

Ischaemic heart disease, wide definition

0.00

0.42

0.0

1.1

—

External causes of morbidity and mortality

1.39

0.42

1.3

—

Other bacterial diseases

1.38

0.42

1.1

1.3

—

Fenamates

0.00

0.41

0.0

1.2

—

Type1 diabetes, definitions combined, early onset

0.00

0.41

0.0

1.3

—

Other specified and unspecified personality disorders

0.00

0.41

0.0

1.3

—

Pain in thoracic spine

0.00

0.41

0.0

1.3

—

L04AA Selective immunosuppressants

0.00

0.41

0.0

1.3

—

Cervical disc disorders

0.00

0.41

0.0

1.1

—

Preparation and fitting of bite rail to mouth

0.00

0.41

0.0

1.3

—

Cervicalgia

0.00

0.41

0.0

1.3

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.41

0.0

1.3

—

Type 1 diabetes, definitions combined

0.00

0.41

0.0

1.3

—

Impacted maxillary molar

0.00

0.40

0.0

1.4

—

Superficial injury of ankle and foot

0.00

0.40

0.0

1.4

—

Extrapyramidal and movement disorders

0.00

0.40

0.0

1.2

—

Bacterial Sepsis

0.00

0.40

0.0

1.3

—

Viral infections characterized by skin and mucous membrane lesions

1.47

0.40

1.4

1.2

—

Early lumbar disc prolapse, operated

0.00

0.40

0.0

1.2

—

Type 2 diabetes, strict (exclude DM1)

1.41

0.40

1.3

—

Type 2 diabetes, definitions combined

1.41

0.40

1.3

—

Disorders of gallbladder, biliary tract and pancreas

1.43

0.39

1.5

1.4

—

Depression medications

1.37

0.39

1.4

1.2

—

Osteopathies and chondropathies

1.44

0.39

1.2

1.3

—

Exclusions for E4_PCOS_BROAD

0.00

0.39

0.0

1.3

—

Fracture of shoulder and upper arm

0.00

0.39

0.0

1.3

—

Disorders of choroid and retina

1.40

0.38

1.0

1.2

—

Mental and behavioural disorders due to alcohol

1.39

0.38

1.4

1.3

—

Gingivitis and periodontal diseases

1.38

0.38

1.2

1.3

—

Other heart diseases, wide

1.34

0.37

1.5

1.3

—

Type 2 diabetes, definitions combined, including avohilmo

1.30

0.37

1.3

—

Diseases of the skin and subcutaneous tissue

1.29

0.37

1.3

1.4

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.35

0.37

1.2

1.3

—

Injuries to the knee and lower leg

1.28

0.36

1.3

1.4

—

Cystitis

1.32

0.36

1.4

—

Mood disorders, excluding more controls

1.35

0.36

1.3

—

Appendectomy

0.64

0.35

1.6

1.3

—

Dental operations

1.40

0.35

1.2

1.5

—

Dental operations, only avohilmo

1.40

0.35

1.2

1.5

—

Migraine with aura

1.43

0.35

1.5

1.3

—

HSIL lesion of the cervix uteri

1.40

0.35

1.7

1.3

—

Sciatica+with lumbago

1.39

0.35

1.7

1.3

—

Hypertension, essential

1.37

0.35

1.0

1.3

—

Fracture of forearm

1.37

0.34

1.3

1.2

—

HSIL lesion of the cervix uteri, vagina or vulva

1.36

0.34

1.7

1.4

—

Second line medication for Crohn's disease

1.36

0.34

1.0

1.3

—

Opioids

1.26

0.34

1.3

—

1.29

0.32

1.5

1.3

—

Use of hypnotics and sedatives

0.69

0.31

1.1

1.4

—

Asthma (mode)

1.34

0.31

1.5

1.3

—

Complications of medical and surgical care

1.33

0.31

1.1

1.4

—

Transport accidents

1.32

0.31

1.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.32

0.30

1.1

1.4

—

Neoplasms

1.25

0.30

1.2

1.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.31

0.30

1.1

1.3

—

Other antidepressants

1.28

0.30

1.4

1.2

—

Diseases of oesophagus, stomach and duodenum

0.74

0.30

1.3

1.4

—

Asthma/COPD (KELA code 203)

0.73

0.29

1.5

1.3

—

Disorders of breast

1.25

0.29

1.3

1.4

—

Asthma (only as main-diagnosis)

1.34

0.29

1.4

1.3

—

Polyarthropathies

1.27

0.28

1.3

—

Asthma

1.31

0.27

1.5

1.3

—

Dislocation, sprain and strain of joints and ligaments of knee

1.26

0.27

1.4

1.3

—

Asthma (only as main-diagnosis), excluding more controls

1.32

0.27

1.4

1.3

—

Asthma, excluding more controls

1.30

0.26

1.5

1.3

—

Suppurative and unspecified otitis media

0.70

0.26

1.2

1.4

—

Mood [affective] disorders

1.24

0.26

1.4

—

Influenza and pneumonia

1.24

0.26

1.2

1.4

—

Mood disorders

1.24

0.25

1.4

—

Dental caries 3 and operation codes, only avohilmo

1.40

0.24

1.4

1.3

—

Diseases of appendix

0.74

0.24

1.5

1.3

—

Appendicitis, broad definition

0.74

0.24

1.5

1.3

—

Anaemias

1.33

0.23

1.4

1.2

—

Diseases of middle ear and mastoid

1.24

0.23

1.3

1.4

—

Disorders of conjunctiva

1.24

0.22

1.3

1.4

—

Injuries to the ankle and foot

0.76

0.22

1.1

1.4

—

Substance abuse, excluding more controls

1.25

0.22

1.4

1.3

—

Female genital prolapse

0.00

0.22

0.0

1.5

—

Reimbursement for rheumatic diseases

1.25

0.22

1.6

1.3

—

Angina pectoris

0.00

0.22

0.0

1.1

—

Coronary revascularization (ANGIO or CABG)

0.00

0.22

0.0

1.0

—

Other and unspecified dermatitis

1.22

0.22

1.2

1.3

—

Other arthrosis

0.00

0.22

0.0

1.0

—

Heart failure, strict

0.00

0.22

0.0

1.1

—

Heart failure,strict

0.00

0.22

0.0

1.1

—

Other disorders of skin and subcutaneous tissue

1.21

0.21

1.2

1.3

—

Other chronic obstructive pulmonary disease

0.00

0.21

0.0

1.1

—

Benign neoplasm: Colon

0.00

0.21

0.0

1.1

—

COPD

0.00

0.21

0.0

1.1

—

L04AX Other immunosuppressants

1.19

0.21

1.0

1.3

—

Mixed and other personality disorders

0.00

0.21

0.0

1.1

—

Pruritus

0.00

0.21

0.0

1.3

—

Rosacea

0.00

0.21

0.0

1.3

—

Purpura and other haemorrhagic conditions

0.00

0.21

0.0

1.3

—

Direct fill therapy

0.00

0.21

0.0

1.2

—

Glomerular diseases

0.00

0.21

0.0

1.1

—

Other diseases of blood and blood-forming organs, wide

0.00

0.21

0.0

1.2

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.21

0.0

1.2

—

Chronic periapical parodontitis

0.00

0.21

0.0

1.2

—

Alcohol dependence

0.00

0.21

0.0

1.1

—

Benign lipomatous neoplasm

0.00

0.21

0.0

1.1

—

Benign lipomatous neoplasm

0.00

0.21

0.0

1.1

—

Other diseases of the digestive system

0.00

0.21

0.0

1.2

—

GI-bleeding

0.00

0.21

0.0

1.2

—

Major coronary heart disease event

0.00

0.21

0.0

1.1

—

Chalazion

0.00

0.21

0.0

1.2

—

Implicit viral Sepsis

0.00

0.21

0.0

1.2

—

Viral Sepsis

0.00

0.21

0.0

1.2

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

0.21

0.0

1.1

—

COPD, hospital admissions

0.00

0.21

0.0

1.1

—

COPD, early/later onset

0.00

0.21

0.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

0.00

0.21

0.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

1.25

0.21

1.3

—

Other and unspecified mood [affective] disorders

0.00

0.21

0.0

1.2

—

Mental disorders, not otherwise specified

0.00

0.21

0.0

1.3

—

Allergic contact dermatitis

0.00

0.21

0.0

1.3

—

Injury of eye and orbit

0.00

0.21

0.0

1.3

—

Schizophrenia

0.00

0.21

0.0

1.2

—

Other disorders of teeth and supporting structures

0.00

0.21

0.0

1.2

—

Hypertensive diseases

1.26

0.20

1.0

1.3

—

Hypertension

1.26

0.20

1.0

1.3

—

Type 2 diabetes

1.26

0.20

1.3

1.4

—

Dizziness and giddiness

1.25

0.20

1.0

1.4

—

Early lumbar disc prolapse operation

0.00

0.20

0.0

1.3

—

Cellulitis

0.00

0.20

0.0

1.3

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.20

0.0

1.3

—

Type 1 diabetes, strict definition

0.00

0.20

0.0

1.3

—

Mental and behavioural disorders due to psychoactive substance use

1.23

0.20

1.3

—

Speech and linguistic disorders

0.00

0.20

0.0

1.3

—

Constipation

1.16

0.19

1.2

1.4

—

Inflammatory bowel disease treatment related agents

1.18

0.19

1.4

1.3

—

Other diseases of urinary system

1.19

0.18

1.3

1.4

—

Other external causes of accidental injury

1.21

0.18

1.2

1.3

—

Accidents

1.21

0.18

1.2

1.3

—

Excessive attrition of teeth

1.19

0.18

1.1

1.3

—

Other diseases of intestines

1.18

0.18

1.2

1.4

—

Parodontitis or/and operation codes

0.74

0.17

1.0

1.4

—

Symptoms and signs involving the skin and subcutaneous tissue

1.12

0.17

1.0

1.4

—

Other joint disorders

1.17

0.17

1.4

1.3

—

Complications of procedures, not elsewhere classified

0.71

0.16

1.2

1.4

—

General symptoms and signs

1.16

0.16

1.1

1.4

—

Benign neoplasms

0.85

0.16

1.3

1.4

—

Acute appendicitis

0.78

0.15

1.5

1.3

—

Pneumonia, organism unspecified

1.16

0.15

1.1

1.4

—

Asthma, including avohilmo

0.85

0.15

1.5

1.3

—

Other anxiety disorders

1.16

0.15

1.4

1.3

—

Diseases of the ear and mastoid process

1.15

0.15

1.2

1.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

0.77

0.14

1.4

—

First line medication for Crohn's disease

1.15

0.14

1.5

1.3

—

Diseases of the eye and adnexa

0.86

0.13

1.2

1.4

—

Other specific joint derangements/joint disorders

0.83

0.13

1.6

1.3

—

Codeine

1.13

0.11

1.2

1.4

—

Falls/tendency to fall

0.89

0.11

1.3

1.4

—

Benign neoplasms

0.88

0.10

1.3

1.4

—

1.15

0.10

1.4

1.3

—

Dental pulpitis 3

1.12

0.10

1.2

1.3

—

Arthropathies

1.12

0.10

1.4

1.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.14

0.10

1.2

1.3

—

Leiomyoma of uterus

1.09

0.10

1.0

1.3

—

Leiomyoma of uterus

1.08

0.10

1.0

1.3

—

Hypertensive diseases (excluding secondary)

1.08

0.09

1.0

1.3

—

Sleep apnoea

1.06

0.09

1.2

1.3

—

1.07

0.09

1.4

1.2

—

Dermatitis

1.06

0.09

1.2

1.4

—

Other acute lower respiratory infections

1.06

0.09

1.2

1.3

—

Substance abuse

1.04

0.09

1.4

1.3

—

Asthma, hospital admissions , main diagnosis only

1.15

0.09

1.4

1.3

—

Parodontitis and operation codes

1.11

0.09

1.0

1.3

—

Other disorders of ear

1.08

0.09

1.2

1.3

—

Asthma, hospital admission 2, infections

1.09

0.09

1.5

1.3

—

Asthma-related infections

1.09

0.09

1.5

1.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.88

0.08

1.2

1.4

—

Triptan medication for migraine, single purchase ok

0.88

0.08

1.2

1.4

—

Finngen Rheumatological endpoints

1.12

0.08

1.3

1.4

—

Dorsopathies

0.90

0.08

1.5

1.3

—

Chronic periodontitis, including avohilmo

1.03

0.08

1.0

1.3

—

Parodontitis

1.03

0.08

1.0

1.3

—

Parodontitis or operation codes

1.03

0.08

1.0

1.3

—

Disorders of skin appendages

1.03

0.08

1.3

—

Disorders of eyelid, lacrimal system and orbit

0.80

0.08

1.0

1.3

—

Metabolic disorders

1.11

0.08

1.1

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.83

0.08

1.2

1.4

—

Benzodiazepine use

1.12

0.08

1.6

1.3

—

Acute appendicitis, no complications

0.77

0.08

1.6

1.4

—

Diabetes, varying definitions

1.13

0.08

1.3

1.4

—

Diabetes mellitus

1.13

0.08

1.3

1.4

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.03

0.07

1.3

1.4

—

Temporomandibular joint disorders, including avohilmo

0.82

0.07

1.5

1.3

—

Autoimmune diseases excluding thyroid diseases

1.11

0.07

1.2

1.4

—

Sleep disorders (combined)

1.07

0.07

1.3

—

Pain in throat and chest

1.04

0.07

1.3

1.4

—

Atopic dermatitis

0.86

0.07

1.1

1.4

—

Cardiovascular diseases

1.09

0.05

1.2

1.4

—

Codeine or tramadol medication

1.08

0.05

1.2

1.4

—

Other dorsopathies, not elsewhere classified

0.93

0.04

1.4

1.3

—

Asthma (diagnoses ohter than nonallergic)

1.10

0.04

1.5

1.3

—

Any reimbursement code in KELA

0.92

0.03

1.3

—

Conjunctivitis

1.09

0.03

1.3

1.4

—

1.08

0.02

1.1

1.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.08

0.02

1.1

1.3

—

Chronic lower respiratory diseases

0.95

0.02

1.4

1.3

—

Exclusions for E4_PCOS_CONSORTIUM

0.94

0.01

1.0

1.4

—

Dorsalgia

0.95

0.01

1.5

1.3

—

Dermatitis and eczema

1.05

0.01

1.2

1.4

—

Injuries to the head

0.95

0.00

1.4

1.3

—

All pneumoniae

0.95

0.00

1.1

1.4

—

Lower back pain or/and sciatica

1.03

0.00

1.5

1.3

—

Pneumonias (Asthma/COPD co-morbidities)

0.98

0.00

1.1

1.4

—

Oral corticosteroids

0.96

0.00

1.5

1.3

—

ILD medications

0.97

0.00

1.4

1.3

—

Cardiovascular diseases (excluding rheumatic etc)

1.02

0.00

1.2

1.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.04

0.00

1.2

1.4

—

Antihypertensive medication - note that there are other indications

1.00

0.00

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

0.98

0.00

1.5

1.3

—

Diabetes medication

1.05

0.00

1.3

1.4

—

Injuries to the wrist and hand

0.97

0.00

1.3

1.4

—

Viral meningitis

0.00

0.0

1.2

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.0

1.2

—

Event of undetermined intent

0.00

0.0

1.2

—

Glomerular disorders in diseases classified elsewhere

0.00

0.0

1.2

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.0

1.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

0.0

1.1

—

Lichen planus

0.00

0.0

1.2

—

Foreign body or object entering through skin

0.00

0.0

1.0

—

Missing teeth due to accident, extraction or parodontitis

0.00

0.0

1.4

—

Adalimumab

0.00

0.0

1.3

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.0

1.3

—

Benign neoplasm of ovary

0.00

0.0

1.3

—

Acute tubulo-interstitial nephritis

0.85

0.00

1.0

1.4

—

Cluster headache, strict, including avohilmo

0.00

0.0

1.2

—

Malignant melanoma

0.00

0.0

1.2

—

Nasal polyp

0.00

0.0

1.1

—

Vitreous haemorrhage

0.00

0.0

1.2

—

Chronic iridocyclitis

0.00

0.0

1.2

—

Other disorders of the genitourinary system

0.00

0.0

1.2

—

Emergency coronary revascularization (for ACS)

0.00

0.0

1.0

—

Certain disorders involving the immune mechanism

0.00

0.0

1.1

—

Disorders of tooth development and eruption

0.00

0.0

1.4

—

All-cause Heart Failure

0.00

0.0

1.1

—

Mixed disorders of conduct and emotions

0.00

0.0

1.2

—

Other diseases of jaws

0.00

0.0

1.4

—

Zoster [herpes zoster]

0.00

0.0

1.0

—

Hidradenitis suppurativa

0.00

0.0

1.2

—

Sarcoidosis

0.00

0.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.0

1.1

—

Dissociative [conversion] disorders

0.00

0.0

1.0

—

Herpesviral [herpes simplex] infections

0.00

0.0

1.1

—

Gastric ulcer

0.00

0.0

1.0

—

Agranulocytosis

0.00

0.0

1.2

—

Other and unspecified rosacea

0.00

0.0

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

0.0

1.1

—

Seborrhoeic keratosis

0.00

0.0

1.1

—

Explicit bacterial Sepsis

0.00

0.0

1.2

—

Soft tissue disorders related to use, overuse and pressure

0.00

0.0

1.1

—

Hyperprolactinaemia

0.00

0.0

1.2

—

Scleritis and episcleritis

0.00

0.0

1.2

—

Other osteochondropathies

0.00

0.0

1.2

—

Astigmatism

0.00

0.0

1.3

—

malignant neoplasm of female genital organs

0.00

0.0

1.2

—

Melanocytic naevi of lower limb, including hip

0.00

0.0

1.2

—

Specific development disorders of scholastic skills

0.00

0.0

1.2

—

Other infective otitis externa

0.00

0.0

1.2

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

0.0

1.2

—

Schizoaffective disorder

0.00

0.0

1.1

—

Other disorders of bladder

0.00

0.0

1.2

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.0

1.1

—

Speech and linguistic disorders, excluding more controls

0.00

0.0

1.1

—

Glomerulonephritis

0.00

0.0

1.2

—

Benign neoplasm of major salivary glands

0.00

0.0

1.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

1.2

—

Hyperfunction of pituitary gland

0.00

0.0

1.2

—

Exposure to other and unspecified inanimate mechanical forces

0.00

0.0

1.2

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.2

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

1.2

—

Other inflammation of eyelid

0.00

0.0

1.1

—

Haemangioma, any site

0.00

0.0

1.2

—

Persons encountering health services for specific procedures, not carried out

0.00

0.0

1.3

—

Fitting and adjustment of other devices

0.00

0.0

1.1

—

Presence of cardiac and vascular implants and grafts

0.00

0.0

1.1

—

Adjustment and management of implanted device

0.00

0.0

1.2

—

Other and unspecified drugs and medicaments

0.00

0.0

1.2

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.96

0.00

1.1

1.4

—

Desensitization to allergens

0.00

0.0

1.3

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

0.0

1.2

—

Hordeolum and other deep inflammation of eyelid

0.00

0.0

1.2

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.0

1.2

—

Pedestrian injured in transport accident

0.00

0.0

1.2

—

Malignant neoplasm of endocrine gland

0.00

0.0

1.2

—

Injuries to the shoulder and upper arm

0.87

0.00

1.0

1.3

—

Exposure to other and unspecified animate mechanical forces

0.00

0.0

1.2

—

Struck by thrown, projected or falling objec

0.00

0.0

1.2

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.0

1.2

—

Benign neoplasm: Colon

0.00

0.0

1.1

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.97

0.00

1.0

1.4

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.0

1.3

—

Other complications of surgical and medical care, not elsewhere classified

0.00

0.0

1.2

—

Other and unspecified injuries of lower leg

0.00

0.0

1.1

—

Foreign body on external eye

0.00

0.0

1.2

—

Contusion of other and unspecified parts of foot

0.00

0.0

1.3

—

Other and unspecified injuries of wrist and hand

0.00

0.0

1.2

—

L04AD Calcineurin inhibitors

0.00

0.0

1.2

—

Injury of muscle and tendon at lower leg level

0.00

0.0

1.1

—

Benign leiomyoma with endometriosis

0.00

0.0

1.1

—

Acute and transient psychotic disorders

0.00

0.0

1.1

—

Sequelae of injuries of head

0.00

0.0

1.2

—

Complications of the puerperium, not elsewhere classified

0.00

0.0

1.2

—

Sequelae of injuries of upper limb

0.00

0.0

1.1

—

Abnormal serum enzyme levels

0.00

0.0

1.1

—

Cramp and spasm

0.00

0.0

1.2

—

Rash and other nonspecific skin eruption

0.00

0.0

1.2

—

Sleep apnoea, including avohilmo

0.95

0.00

1.2

1.4

—

Other/unspecified reactive arthropathies

0.00

0.0

1.2

—

Somnolence, stupor and coma

0.00

0.0

1.2

—

Headache

0.98

0.00

1.3

1.4

—

Other embolism and thrombosis

0.00

0.0

1.1

—

Use of pramipexole

0.00

0.0

1.1

—

Pacemaker

0.00

0.0

1.0

—

Other otitis externa (chronic)

0.00

0.0

1.2

—

Opening and dilatation of root channel of tooth

0.00

0.0

1.3

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Episcleritis

0.00

0.0

1.2

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Mixed conductive and sensorineural hearing loss

0.00

0.0

1.2

—

Bilateral sagittal split ramus osteotomy operation

0.00

0.0

1.2

—

LeFortI or BSSRO operation

0.00

0.0

1.2

—

Use of interferon beta-1a

0.00

0.0

1.2

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.0

1.2

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

0.0

1.2

—

Benign neoplasm of major salivary glands

0.00

0.0

1.0

—

Lichen planus, including avohilmo

0.00

0.0

1.1

—

Scar conditions and fibrosis of skin

0.00

0.0

1.2

—

Ingrowing nail

0.00

0.0

1.2

—

Bell's palsy

0.00

0.0

1.1

—

Benign mammary dysplasia

0.00

0.0

1.2

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Dermatophytosis

0.00

0.0

1.2

—

Benign neoplasm of ovary

0.00

0.0

1.2

—

Low back pain

0.96

0.00

1.2

1.3

—

Gastroduodenal ulcer

0.00

0.0

1.1

—

Achilles tendinitis

0.00

0.0

1.1

—

Other inflammatory liver diseases

0.00

0.0

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

0.0

1.2

—

severe traumatic brain injury, does not include concussion

0.00

0.0

1.2

—

Crossbite

0.00

0.0

1.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

1.1

—

Dental caries 2 and operation codes, only avohilmo

1.02

0.00

1.1

1.3

—

Coronary angioplasty

0.00

0.0

1.0

—

Diseases of peritoneum

0.00

0.0

1.2

—

Divergent concomitant strabismus

0.00

0.0

1.1

—

Primary gonarthrosis, bilateral

0.00

0.0

1.1

—

Benign leiomyoma with endometriosis

0.00

0.0

1.2

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

1.1

—

Early onset COPD

0.00

0.0

1.1

—

Infective dermatitis

0.00

0.0

1.0

—

Crohn disease (strict definition, all UC cases excluded)

0.00

0.0

1.2

—

Allergic conjunctivitis

0.94

0.00

1.3

1.4

—

ILD medications: immunosuppressive drugs

0.86

0.00

1.0

1.4

—

Other endocrine disorders

0.00

0.0

1.2

—

Major coronary heart disease event excluding revascularizations

0.00

0.0

1.0

—

Suppurative otitis media, unspecified

0.00

0.0

1.2

—

Renal tubulo-interstitial diseases

0.99

0.00

1.1

1.4

—

Nonsuppurative otitis media

0.96

0.00

1.4

1.3

—

Myocardial infarction

0.00

0.0

1.0

—

Chronic suppurative otitis media, including avohilmo

0.00

0.0

1.2

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Otalgia

0.00

0.0

1.3

—

Fracture of lumbar spine and pelvis

0.00

0.0

1.1

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.0

1.2

—

Maternal care for known or suspected disproportion

0.00

0.0

1.2

—

Conductive hearing loss, unspecified

0.00

0.0

1.1

—

Other follicular disorders

0.00

0.0

1.1

—

Other congenital malformations of face and neck

0.00

0.0

1.2

—

Chronic viral hepatitis

0.00

0.0

1.2

—

Specific development disorders of speech and language

0.00

0.0

1.1

—

Disorders of eyelid in diseases classified elsewhere

0.00

0.0

1.2

—

Restless leg syndrome

0.00

0.0

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

0.00

0.0

1.2

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Cerebral cysts

0.00

0.0

1.2

—

Cerebral palsy and other paralytic syndromes

0.00

0.0

1.2

—

Unstable angina pectoris

0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.2

—

Disorders of speech understanding and production

0.00

0.0

1.2

—

Infections of the skin and subcutaneous tissue

0.89

0.00

1.2

1.3

—

Other disorders of cornea

0.00

0.0

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.01

0.00

1.4

1.3

—

Agoraphobia

0.00

0.0

1.2

—

Implicit bacterial Sepsis

0.00

0.0

1.1

—

Lesion of ulnar nerve

0.00

0.0

1.2

—

Cluster headache, wide,, including avohilmo

0.00

0.0

1.2

—

Hypoglycaemia, other or unspecified

0.00

0.0

1.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.0

1.1

—

Dermatitis due to ingested food

0.00

0.0

1.2

—

Suggestive for eosinophilic asthma

0.00

0.0

1.2

—

COPD related to multimorbidity

0.00

0.0

1.0

—

Blepharochalasis

0.00

0.0

1.2

—

COPD, hospital admission 2, with asthma infections

0.00

0.0

1.0

—

Other appendicitis

0.00

0.0

1.1

—

Nonspecific lymphadenitis

0.00

0.0

1.2

—

Myocardial infarction, strict

0.00

0.0

1.0

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.0

1.1

—

Other peripheral vertigo

0.00

0.0

1.2

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.2

—

Collagenous colitis

0.00

0.0

1.2

—

Cardiomyopathy

0.00

0.0

1.2

—

Nonalcoholic fatty liver disease

0.00

0.0

1.2

—

Glaucoma suspect

0.00

0.0

1.1

—

Cardiodefibrillation

0.00

0.0

1.0

—

Haemangioma, any site

0.00

0.0

1.2

—

Papillary adenocarcinoma of thyroid gland

0.00

0.0

1.2

—

Nail disorders

0.00

0.0

1.2

—

Malignant neoplasm of thyroid gland

0.00

0.0

1.2

—

Non-ischemic cardiomyopathy

0.00

0.0

1.2

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

DVT of lower extremities

0.00

0.0

1.1

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Chronic laryngitis and laryngotracheitis

0.00

0.0

1.0

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.0

1.2

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

0.0

1.0

—

Any event in cancer register

0.94

0.00

1.3

1.4

—

Radiculopathy

0.00

0.0

1.1

—

Malignant neoplasm of breast, HER-negative

0.00

0.0

1.2

—

Algoneurodystrophy

0.00

0.0

1.2

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

0.0

1.0

—

Open bite

0.00

-0.00

0.0

1.4

—

Other and unspecified polyneuropathies, also in other diseases

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Listeria sp Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS